Literature DB >> 22362252

Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2.

Obul R Bandapalli1, Stephan Macher-Goeppinger, Peter Schirmacher, Karsten Brand.   

Abstract

In a nude mouse model of colorectal liver metastases, we have identified a paracrine tumor cell/host cell signalling pathway that is apparently required for successful tumor growth. Whereas recombinant platelet derived growth factor-C (PDGF-C) and supernatants from PDGF-C secreting wild type LS174T colon carcinoma cells could rescue tumor promoting hepatic stellate cells (HSC) from growth inhibition by serum starvation, supernatants from LS174T colon carcinoma cells with reduced secretion of PDGF-C had much less effect on serum starved HSC. Autocrine growth inhibition of LS174T cells by PDGF-C knock-down was only marginal. In vivo, a prominent inhibition of liver metastasis was observed if PDGF-C was knocked-down in LS174T cells. By whole genome array analysis of host cells of the invasion front and subsequent immunohistochemical staining we identified p21 activated kinase-2 (PAK-2) as being strongly and specifically expressed by HSC. The above described effect of PDGF-C on HSC was found to be dependent on PAK-2 because in contrast to wild type HSC, silencing of PAK-2 in HSC only allowed for a partial PDGF-C-mediated rescue from serum starvation leading to only a slight increase of proliferation. These data indicate that PDGF-C promotes tumor growth via a growth promoting effect on HSC that is at least in part dependent on the presence of functional PAK-2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362252     DOI: 10.1007/s10585-012-9459-3

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

1.  Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases.

Authors:  Obul Reddy Bandapalli; Nawid Hariri; Stephan Macher-Göppinger; Christoph Kahlert; Peter Schirmacher; Karsten Brand
Journal:  Anticancer Res       Date:  2011-04       Impact factor: 2.480

2.  Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.

Authors:  Jean S Campbell; Steven D Hughes; Debra G Gilbertson; Thomas E Palmer; Matthew S Holdren; Aaron C Haran; Melissa M Odell; Renay L Bauer; Hong-Ping Ren; Harald S Haugen; Matthew M Yeh; Nelson Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

3.  Human breast carcinoma desmoplasia is PDGF initiated.

Authors:  Z M Shao; M Nguyen; S H Barsky
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

4.  Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors.

Authors:  Alexander Beeser; Zahara M Jaffer; Clemens Hofmann; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

5.  Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma.

Authors:  Max L Tejada; Lanlan Yu; Jianying Dong; Kenneth Jung; Gloria Meng; Franklin V Peale; Gretchen D Frantz; Linda Hall; XiaoHuan Liang; Hans-Peter Gerber; Napoleone Ferrara
Journal:  Clin Cancer Res       Date:  2006-05-01       Impact factor: 12.531

Review 6.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells.

Authors:  Elisabetta Rovida; Nadia Navari; Alessandra Caligiuri; Persio Dello Sbarba; Fabio Marra
Journal:  J Hepatol       Date:  2007-10-17       Impact factor: 25.083

8.  Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.

Authors:  Salvatore J Coniglio; Salvatore Zavarella; Marc H Symons
Journal:  Mol Cell Biol       Date:  2008-04-14       Impact factor: 4.272

9.  Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion.

Authors:  M Mikula; V Proell; A N M Fischer; W Mikulits
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

10.  Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens.

Authors:  Obul Reddy Bandapalli; Christoph Kahlert; Victoria Hellstern; Luis Galindo; Peter Schirmacher; Jürgen Weitz; Karsten Brand
Journal:  BMC Genomics       Date:  2008-09-29       Impact factor: 3.969

View more
  9 in total

1.  Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.

Authors:  Jocelyn H Wright; Melissa M Johnson; Masami Shimizu-Albergine; Renay L Bauer; Brian J Hayes; James Surapisitchat; Kelly L Hudkins; Kimberly J Riehle; Simon C Johnson; Matthew M Yeh; Theodor K Bammler; Richard P Beyer; Debra G Gilbertson; Charles E Alpers; Nelson Fausto; Jean S Campbell
Journal:  Int J Cancer       Date:  2013-09-16       Impact factor: 7.396

2.  PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.

Authors:  Katherine Martin; James Pritchett; Jessica Llewellyn; Aoibheann F Mullan; Varinder S Athwal; Ross Dobie; Emma Harvey; Leo Zeef; Stuart Farrow; Charles Streuli; Neil C Henderson; Scott L Friedman; Neil A Hanley; Karen Piper Hanley
Journal:  Nat Commun       Date:  2016-08-18       Impact factor: 17.694

Review 3.  Targeting the PDGF signaling pathway in tumor treatment.

Authors:  Carl-Henrik Heldin
Journal:  Cell Commun Signal       Date:  2013-12-20       Impact factor: 5.712

Review 4.  Pharmacodynamic Biomarker Development for PI3K Pathway Therapeutics.

Authors:  Debra H Josephs; Debashis Sarker
Journal:  Transl Oncogenomics       Date:  2016-02-21

5.  MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis.

Authors:  Chun-Ting Hu; Li-Li Guo; Na Feng; Lei Zhang; Na Zhou; Li-Li Ma; Lan Shen; Gui-Hui Tong; Qian-Wen Yan; Shi-Jie Zhu; Xiu-Wu Bian; Mao D Lai; Yong-Jian Deng; Yan-Qing Ding
Journal:  Oncotarget       Date:  2015-09-08

6.  PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently.

Authors:  Lei Zheng; Chen Zhao; Yuxiang Du; Xianchai Lin; Yida Jiang; Chunsik Lee; Geng Tian; Jia Mi; Xianglin Li; Qishan Chen; Zhimin Ye; Lijuan Huang; Shasha Wang; Xiangrong Ren; Liying Xing; Wei Chen; Delong Huang; Zhiqin Gao; Shuping Zhang; Weisi Lu; Zhongshu Tang; Bin Wang; Rong Ju; Xuri Li
Journal:  Oncotarget       Date:  2016-11-22

7.  The Role Of Hepatic Stellate Cells In Promoting Liver Metastasis Of Colorectal Carcinoma.

Authors:  Wen-Hai Huang; Min-Wei Zhou; Yan-Feng Zhu; Jian-Bin Xiang; Zhen-Yang Li; Zi-Hao Wang; Yi-Ming Zhou; Yi Yang; Zong-You Chen; Xiao-Dong Gu
Journal:  Onco Targets Ther       Date:  2019-09-16       Impact factor: 4.147

8.  Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2.

Authors:  Qing Zhou; Tengfei Gu; Yong Zhang; Hongda Li; Xuemei Zhuansun; Sanrong Xu; Yuting Kuang
Journal:  Biomed Res Int       Date:  2021-02-25       Impact factor: 3.411

Review 9.  Review: Challenges of In Vitro CAF Modelling in Liver Cancers.

Authors:  Alba Herrero; Elisabeth Knetemann; Inge Mannaerts
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.